1 not yet recruiting. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
Follow Relapsed Peripheral T-Cell Lymphoma: new trials by email Literature Review of Relapsed Peripheral T-Cell Lymphoma trials Research Report on Relapsed Peripheral T-Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pralatrexate Combined With Chidamide Bridging Allogeneic HSCT for Refractory/Relapsed Peripheral T-cell Lymphoma Pralatrexate combined with Chidamide bridging Allogeneic Hematopoietic Stem Cell Transplantation - Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma | Not applicable | Not yet recruiting | Peking University People's Hospital | 25 | 2024-12-01 | 2024-11-06 |
Lymphoma, T-Cell, Peripheral (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Peking University People's Hospital (1)
China (1)
Xiaodong Mo (1)